GLP-1 Supplements: Do Boosters Work? What Studies Show
GLP-1 supplements are pills and powders that claim to help your body make more of its own GLP-1 hormone. The five labels we read listed no GLP-1 drug. We read seven human studies across six booster ingredients. Three found GLP-1 went up, two found no gain, and two never measured it.
The short version
- Mixed results: lemon flavonoids, a lemon verbena mix and one fiber study measured a rise.
- Gaps: the berberine and probiotic trials we read did not measure GLP-1 at all.
- Not the drug: your own GLP-1 is broken down very fast; semaglutide is built to last about a week.
Most pages for this search sell a product or list five herbs. This one puts each ingredient next to the GLP-1 change its human study measured, then adds our read of five real labels.
Sources: Ribeiro CB and colleagues. "Effectiveness of Eriomin® in managing hyperglycemia and reversal of prediabetes condition: A double-blind, randomized, controlled study." Phytotherapy Research, 2019. PMID 31183921.; Perraudeau F and colleagues, BMJ Open Diabetes Research and Care, 2020, a placebo-controlled trial of a five-strain probiotic in type 2 diabetes run by the maker of the strains. PMID 32675291. Full text read on PubMed Central.; The US Ozempic label for semaglutide injection on DailyMed, which we read on 23 October 2026: sequence match to human GLP-1, stability against DPP-4, and a half-life near one week.
What did each booster ingredient do to GLP-1?
We picked the ingredients these products list most, plus yerba mate. For each one we read a human study and noted what happened to GLP-1 in the blood. Fiber gets two rows because two trials, in different groups of people, disagree.
| Ingredient | Human study | Who and how long | GLP-1 result | What was measured |
|---|---|---|---|---|
| Prebiotic fiber (oligofructose type) | Cani and colleagues, American Journal of Clinical Nutrition, 2009 | 10 healthy adults, 2 weeks | Rose | GLP-1 after a test meal went up; the abstract gives no percentage |
| Prebiotic fiber (inulin type) | Birkeland and colleagues, Diabetic Medicine, 2021 | 29 adults with type 2 diabetes, 6 weeks each arm | No gain | No gain: the meal GLP-1 response was 4.8% lower after the fiber and 8.6% higher after the dummy powder |
| Probiotic blend with Akkermansia | Perraudeau and colleagues, BMJ Open Diabetes Research and Care, 2020 | 76 adults with type 2 diabetes, 12 weeks | Not measured | Not measured; the paper says GLP-1 levels were not directly measured |
| Berberine | Yin, Xing and Ye, Metabolism, 2008 | Two 3-month studies: 36 adults randomised to berberine or metformin, and 48 adults given berberine on top of their treatment | Not measured | Not measured; the trial tracked blood sugar and HbA1c |
| Yerba mate | Bravo and colleagues, Molecular Nutrition and Food Research, 2025 | healthy and high cholesterol adults, 8 weeks | No gain | No change in GLP-1 (GIP and ghrelin fell) |
| Lemon flavonoids (Eriomin) | Ribeiro and colleagues, Phytotherapy Research, 2019 | 103 adults with prediabetes, 12 weeks | Rose | Up 15% |
| Lemon verbena with hibiscus | Boix-Castejon and colleagues, Food and Function, 2018 | 54 overweight adults, 60 days | Rose | Went up; the abstract gives no percentage |
| Our tally of the seven studies | Count |
|---|---|
| GLP-1 rose | 3 of 7 |
| No gain in GLP-1 | 2 of 7 |
| GLP-1 not measured | 2 of 7 |
Method: we read each abstract, and the full text where the abstract was silent, then sorted the GLP-1 result as rose, no gain, or not measured. A rise in a hormone is a lab number. It is not proof of weight change, and none of these studies tested a finished GLP-1 booster product.
Two rows need a note. The probiotic trial was run by the company that makes the strains. And the berberine link to GLP-1 comes mostly from lab and animal work, as a 2024 review on the topic describes. Our berberine guide covers the herb in more depth.
Sources: Cani PD and colleagues. "Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal." American Journal of Clinical Nutrition, 2009. PMID 19776140.; Birkeland E and colleagues, Diabetic Medicine, 2021: a crossover trial of inulin-type prebiotics against a maltodextrin control in adults with type 2 diabetes. PMID 34297363.; Perraudeau F and colleagues, BMJ Open Diabetes Research and Care, 2020, a placebo-controlled trial of a five-strain probiotic in type 2 diabetes run by the maker of the strains. PMID 32675291. Full text read on PubMed Central.; Yin J, Xing H, Ye J, Metabolism, 2008: a pilot trial of berberine by mouth in adults with type 2 diabetes. PMID 18442638.; Bravo L and colleagues, Molecular Nutrition and Food Research, 2025: a randomized crossover trial of yerba mate tea in adults who did not drink it before. PMID 40263915.; Ribeiro CB and colleagues. "Effectiveness of Eriomin® in managing hyperglycemia and reversal of prediabetes condition: A double-blind, randomized, controlled study." Phytotherapy Research, 2019. PMID 31183921.; Boix-Castejón M and colleagues. "Hibiscus and lemon verbena polyphenols modulate appetite-related biomarkers in overweight subjects: a randomized controlled trial." Food and Function, 2018. PMID 29862395.; Araj-Khodaei M and colleagues. "Berberine-induced glucagon-like peptide-1 and its mechanism for controlling type 2 diabetes mellitus: a comprehensive pathway review." Archives of Physiology and Biochemistry, 2024. PMID 37921026.
How much did the studies give?
The amounts below are what each trial gave its volunteers, as printed in the published abstracts we read on 23 October 2026:
Prebiotic fiber: 16 g a day in both fiber trials. Lemon flavonoids: 200, 400 or 800 mg a day. Berberine: 0.5 g three times a day. Yerba mate: three servings of mate tea a day.
Disclaimer: these are study amounts reported for comparison, not a dose for anyone. No one checks supplement labels against these amounts, and none of these trials tested a finished GLP-1 booster product.
The lemon verbena and hibiscus trial and the probiotic trial do not give a gram amount in their abstracts, so they are left out of this list.
Sources: Cani PD and colleagues. "Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal." American Journal of Clinical Nutrition, 2009. PMID 19776140.; Birkeland E and colleagues, Diabetic Medicine, 2021: a crossover trial of inulin-type prebiotics against a maltodextrin control in adults with type 2 diabetes. PMID 34297363.; Ribeiro CB and colleagues. "Effectiveness of Eriomin® in managing hyperglycemia and reversal of prediabetes condition: A double-blind, randomized, controlled study." Phytotherapy Research, 2019. PMID 31183921.; Yin J, Xing H, Ye J, Metabolism, 2008: a pilot trial of berberine by mouth in adults with type 2 diabetes. PMID 18442638.; Bravo L and colleagues, Molecular Nutrition and Food Research, 2025: a randomized crossover trial of yerba mate tea in adults who did not drink it before. PMID 40263915.
How is your own GLP-1 different from the drug?
Your gut releases GLP-1 after you eat. It helps release insulin, slows the stomach and plays a part in fullness. But an enzyme called DPP-4 breaks it down very fast, often before it even leaves the gut. A physiology review by Jens Juul Holst sets this out.
The drugs were built around that problem. The Ozempic label says semaglutide shares 94% of its sequence with human GLP-1, binds to a blood protein and resists DPP-4. Its half-life is about one week.
So the two work on different things. The boosters in these studies act, if at all, on the body's own short-lived hormone, as in the 15% rise in the lemon flavonoid trial. A drug adds a separate copy that lasts for days.
Sources: Holst JJ, Physiological Reviews, 2007: a review of how the body makes and breaks down its own GLP-1. PMID 17928588.; The US Ozempic label for semaglutide injection on DailyMed, which we read on 23 October 2026: sequence match to human GLP-1, stability against DPP-4, and a half-life near one week.; Ribeiro CB and colleagues. "Effectiveness of Eriomin® in managing hyperglycemia and reversal of prediabetes condition: A double-blind, randomized, controlled study." Phytotherapy Research, 2019. PMID 31183921.
What five GLP-1 supplement labels list
On 23 October 2026 we read the pages of five supplements sold with GLP-1 in the name. We only read them and bought nothing. One brand site would not load, so we read its label on a supplement database listing. We name no brand.
How we picked them: one came from the live US top 10 for this search on 23 October 2026, and the other four are products with GLP-1 printed in the product name. In all, we read four brand product pages and one label database listing.
| Product | Type | Main ingredients listed |
|---|---|---|
| Product 1 | Capsule from a telehealth brand | lemon flavonoids (Eriomin), black ginger, dihydroberberine, a postbiotic |
| Product 2 | Capsule from a celebrity-backed brand | lemon fruit extract (Eriomin), red orange extract, saffron extract |
| Product 3 | Probiotic capsule | Akkermansia muciniphila, Clostridium butyricum, Bifidobacterium infantis |
| Product 4 | Fiber powder | oat beta glucan, resistant potato starch, green banana, soluble vegetable fiber |
| Product 5 | Capsule from a large supplement maker | lemon verbena and hibiscus, berberine, mulberry leaf |
| What we checked | How many of 5 |
|---|---|
| Put GLP-1 in the product name | 5 of 5 |
| Listed GLP-1 or any GLP-1 drug as an ingredient | 0 of 5 |
| Printed an amount for each ingredient | 3 of 5 |
| Showed the US statement that the FDA did not evaluate its claims | 4 of 5 |
| Said it holds no GLP-1, or warned about use with medicines | 3 of 5 |
Two of the five lean on Eriomin, the lemon extract with the clearest GLP-1 result in our table. The probiotic brand marks its GLP-1 claims as based on preclinical studies and says the product is not meant for weight loss. Product 3 printed no strain amounts, and Product 1 printed none for its blend.
This is our own one-day snapshot of five pages, not a survey of the market.
Sources: Our own reading of five GLP-1 branded supplement pages on 23 October 2026, one through a supplement database listing because the brand site did not load. Counts from our own notes.
What have the FDA and FTC said?
The FDA does not review structure or function claims on supplements before sale, which is why labels with such claims carry the line that it has not evaluated them. It can act afterwards. On 24 August 2026 it sent a warning letter about a GLP-1 branded capsule from a New York company. The agency said a new ingredient, a peptide made with yeast, lacked enough evidence to show it was safe. It called the product adulterated and said the firm kept selling it after the FDA had objected.
The FTC handles ads. Its Gut Check guide for media covers dietary supplements and herbal remedies. It lists claims that cannot be true, such as large weight loss no matter what or how much a person eats. A GLP-1 label on a bottle does not change those rules.
Sources: US FDA warning letter CMS 731846 to a New York supplement company, dated 24 August 2026 (read 23 October 2026): its GLP-1 branded capsule was found adulterated because a new yeast-derived ingredient lacked enough safety evidence.; US Federal Trade Commission, Gut Check media guide on false weight loss claims (published January 2014; we read it on 23 October 2026): it covers dietary supplements and herbal remedies, and lists claims of large weight loss no matter what a person eats as false.
Can boosters be taken with a GLP-1 drug?
Two of the five supplement pages raised this question themselves. One says its capsules and GLP-1 medicines are not to be used together. The other tells people on glucose-lowering medicines to talk to a doctor before use.
Berberine is the clearest case. In the 2008 human trial it lowered blood sugar by a similar amount to metformin. Anyone on a drug that also lowers blood sugar has a reason to raise it with their doctor. For food and protein on these drugs, see our GLP-1 meals guide. For patches sold the same way, see our GLP-1 patches label check.
Sources: Our own reading of five GLP-1 branded supplement pages on 23 October 2026, one through a supplement database listing because the brand site did not load. Counts from our own notes.; Yin J, Xing H, Ye J, Metabolism, 2008: a pilot trial of berberine by mouth in adults with type 2 diabetes. PMID 18442638.; The US Ozempic label for semaglutide injection on DailyMed, which we read on 23 October 2026: sequence match to human GLP-1, stability against DPP-4, and a half-life near one week.
Common questions
What supplements should I take if I am on a GLP-1 drug?+
That is a question for the doctor who prescribed the drug, and this page does not pick one. What we can report: one booster label we read says not to use it together with GLP-1 medicines. Another tells people on glucose-lowering medicines to see a doctor first. Berberine lowered blood sugar in a human trial, which matters for anyone already on a drug that does the same.
Is there a natural supplement that matches what Ozempic does?+
None of the studies on this page showed a supplement doing what the drug does. Ozempic holds semaglutide, a long-lasting copy of the GLP-1 hormone. The supplements studied here aim to raise natural GLP-1 release, and the body breaks that hormone down fast. In the studies on this page, three of seven measured a rise.
Is berberine a GLP-1?+
No. Berberine is a yellow plant compound, not a hormone and not a GLP-1 drug. A 2024 review describes ways it may raise GLP-1 release, drawn mostly from lab and animal research. The human berberine trial we read tracked blood sugar and did not measure GLP-1.
Is GLP-1 the same as Ozempic?+
No. GLP-1 is a hormone your gut makes after meals. Ozempic is a brand of semaglutide, a man-made molecule that copies most of the hormone and is built to resist the enzyme that breaks it down. That is why the hormone is broken down fast while the drug stays in the blood for days.
Do GLP-1 supplements contain GLP-1?+
None of the five labels we read listed GLP-1 or a GLP-1 drug. One probiotic brand states on its own page that its product holds no GLP-1 and is not a GLP-1 drug. The ingredients are plant extracts, fibers and bacteria.
Sources: Our own reading of five GLP-1 branded supplement pages on 23 October 2026, one through a supplement database listing because the brand site did not load. Counts from our own notes.; Yin J, Xing H, Ye J, Metabolism, 2008: a pilot trial of berberine by mouth in adults with type 2 diabetes. PMID 18442638.; Araj-Khodaei M and colleagues. "Berberine-induced glucagon-like peptide-1 and its mechanism for controlling type 2 diabetes mellitus: a comprehensive pathway review." Archives of Physiology and Biochemistry, 2024. PMID 37921026.; Holst JJ, Physiological Reviews, 2007: a review of how the body makes and breaks down its own GLP-1. PMID 17928588.; The US Ozempic label for semaglutide injection on DailyMed, which we read on 23 October 2026: sequence match to human GLP-1, stability against DPP-4, and a half-life near one week.
Related pages
This page reports what published human studies and product labels show about GLP-1 booster supplements. It is general reading that endorses no product, and it is not medical advice. Supplements are not a replacement for a prescribed drug.